
("Time Finance", the "Group" or the "Company")
Loan Book Update
Lending Book hits
The Company also reconfirms notice of upcoming investor events and key financial dates
Record Lending Book
As at
Within the lending book itself, the two key strategic growth areas of Invoice Finance and the 'Hard' subset of Asset Finance, have also both achieved all-time record highs. The Invoice Finance lending book stands in excess of
This ongoing positive lending book growth provides the Board with increased confidence that Group financial performance for FY 2025/26 will be at least in line with current market expectations.
Investor Presentations and Key Dates
As announced on
unaudited Interim Results on
Ed Rimmer, CEO, and James Roberts, CFO, will also be presenting at two upcoming investor events on Wednesday
Ends
|
For further information, please contact: |
|
|
|
|
|
|
01225 474230 |
|
Ed Rimmer (CEO) / James Roberts (CFO) |
|
|
|
|
|
Cavendish (NOMAD and Broker) |
0207 220 0500 |
|
Ben Jeynes / Teddy Whiley (Corporate Finance) Michael Johnson / Matt Lewis (Sales and ECM) |
|
|
|
|
|
Walbrook PR |
0207 933 8780 |
|
Nick Rome / Joe Walker |
Subscribe to our news alert service: https://investors.timefinance.com/auth/signup
About Time Finance:
Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.
More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the